# Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer

> **NCT00953225** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 83 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** vitamin D3
- **DRUG:** Placebo daily for one year

## Key facts

- **NCT ID:** NCT00953225
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-07
- **Primary completion:** 2013-12-15
- **Final completion:** 2014-10-30
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953225, "Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00953225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*